Press Release | June 13, 2022
ImCheck Closes Upsized EUR 96 Million (USD 103 Million) Financing to Advance Clinical Program of First-in-human Gamma-delta T Cell Activating Antibody and Accelerate Development of Disruptive Immunotherapeutic Pipeline
Read More
Press Release | May 15, 2022
Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease
Read More
Press Release | May 2, 2022
Gilead follows Big Pharma peers to Dragonfly’s pond in $300M deal for natural killer cell engagers
Read More
Press Release | April 20, 2022
Dragonfly Therapeutics Announces Multi-Target Expansion of its Research Collaboration with AbbVie to Develop Novel Therapeutic Candidates for Immune-Mediated Diseases
Read More
